Qibiao Wu Selected Research

Nonprescription Drugs (Patent Medicines)

6/2021	Evaluation of Zhilong Huoxue Tongyu capsule in the treatment of acute cerebral infarction: A systematic review and meta-analysis of randomized controlled trials.
1/2021	Compound Taxus chinensis Capsule Combined with Chemotherapy for Non-Small-Cell Lung Cancer: A PRISMA-Compliant Systematic Review and Meta-Analysis of Randomized Controlled Trials.
1/2020	Compound Kushen injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 37 RCTs following the PRISMA guidelines.
12/2019	Compound Kushen injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A protocol for meta-analysis of randomized clinical trials following the PRISMA guidelines.
9/2019	Efficacy and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
6/2019	Elemene injection as adjunctive treatment to platinum-based chemotherapy in patients with stage III/IV non-small cell lung cancer: A meta-analysis following the PRISMA guidelines.
7/2018	Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines.
12/2016	A Chinese patent medicine, Shexiang Baoxin Pill, for Non-ST-elevation acute coronary syndromes: A systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qibiao Wu Research Topics

Disease

25	Neoplasms (Cancer) 07/2022 - 01/2019
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 07/2018
9	Lung Neoplasms (Lung Cancer) 07/2022 - 01/2019
3	Inflammation (Inflammations) 02/2022 - 01/2021
3	Cholangiocarcinoma 01/2022 - 12/2021
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2019
3	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2019
3	Hemorrhage 01/2020 - 09/2019
2	Hypoxia (Hypoxemia) 01/2022 - 10/2011
2	Autoimmune Diseases (Autoimmune Disease) 03/2021 - 01/2019
2	Leukopenia 01/2021 - 04/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2019
2	Nausea 04/2020 - 01/2019
2	Anemia 04/2020 - 01/2019
2	Diarrhea 04/2020 - 01/2019
2	Neutropenia 04/2020 - 01/2019
2	Vomiting 04/2020 - 01/2019
1	Stroke (Strokes) 09/2022
1	Colonic Neoplasms (Colon Cancer) 07/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Nocturnal Enuresis (Bedwetting) 01/2022
1	Hypertrophy 01/2022
1	Stomach Neoplasms (Stomach Cancer) 12/2021
1	Disease Progression 10/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2021
1	Cerebral Infarction 06/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2021
1	Arthritis (Polyarthritis) 03/2021
1	Rheumatoid Arthritis 03/2021
1	Fever (Fevers) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Exanthema (Rash) 01/2021
1	Infections 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021

Drug/Important Bio-Agent (IBA)

8	Nonprescription Drugs (Patent Medicines)IBA 06/2021 - 12/2016
7	mesoglycanIBA 09/2022 - 07/2018
7	Pharmaceutical PreparationsIBA 07/2022 - 01/2020
6	PlatinumIBA 02/2020 - 07/2018
4	Biological ProductsIBA 07/2022 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2011
3	Therapeutic UsesIBA 01/2022 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
3	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 01/2020
3	CytokinesIBA 01/2021 - 01/2019
3	elemeneIBA 01/2021 - 06/2019
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 09/2019
2	Phosphotransferases (Kinase)IBA 02/2022 - 10/2021
2	kaempferolIBA 01/2022 - 01/2021
2	LigandsIBA 01/2022 - 12/2021
2	QuercetinIBA 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2022 - 11/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2021 - 01/2019
2	Capsules (Microcapsules)IBA 06/2021 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 04/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 04/2020
2	ErianinIBA 01/2021 - 01/2020
2	kang-lai-teIBA 04/2020 - 02/2020
2	Biomarkers (Surrogate Marker)IBA 04/2020 - 01/2019
2	kushenIBA 01/2020 - 12/2019
2	N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA 01/2020 - 09/2019
1	buyang huanwuIBA 09/2022
1	Long Noncoding RNAIBA 07/2022
1	RNA (Ribonucleic Acid)IBA 07/2022
1	Sphingosine-1-Phosphate ReceptorsIBA 07/2022
1	curcumenolIBA 07/2022
1	NF-kappa B (NF-kB)IBA 02/2022
1	NF-kappaB-Inducing KinaseIBA 02/2022
1	InterferonsIBA 01/2022
1	girinimbineIBA 01/2022
1	sclareolIBA 01/2022
1	CamptothecinIBA 01/2022
1	LuteolinIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	isoimperatorinIBA 01/2022
1	Drug CombinationsIBA 01/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	EnzymesIBA 01/2022
1	HirudinsIBA 01/2022
1	Vincristine (Oncovin)FDA LinkGeneric 01/2022
1	Adenosine Triphosphate (ATP)IBA 12/2021
1	infigratinibIBA 12/2021
1	futibatinibIBA 10/2021
1	sinomenineIBA 03/2021
1	Methotrexate (Mexate)FDA LinkGeneric 03/2021
1	Antirheumatic Agents (DMARD)IBA 03/2021
1	Interleukin-33IBA 03/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	Plant ExtractsIBA 01/2021
1	3-methylquercetinIBA 01/2021
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2021

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2022 - 07/2018
7	Therapeutics 09/2022 - 09/2019
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2019
2	Immunotherapy 01/2022 - 10/2020
1	Neurological Rehabilitation 09/2022
1	Massage (Zone Therapy) 01/2022